Caplight Directory>Investors>LYZZ Capital>Lyzz-capital


LYZZ Capital

LYZZ Capital

Shanghai, Shanghailyzzcap.com

Overview

LYZZ Capital is a leading global healthcare-dedicated VC/PE firm that is actively investing out of USD and RMB funds totaling over USD$600 million . The LYZZ team is composed of highly experienced investment and operating professionals from leading pharmaceutical/biotech companies and Wall Street firms with strong scientific and medical professional backgrounds . They invest in talents, assets, and technologies globally, with an emphasis on unmet medical needs and large market potential in China .

Year Founded

2014

AUM

$600M

Portfolio Companies

5

Investments

CompanyDateStageLead
Onchilles PharmaNov 2025Series A ExtensionCo-investor
WugenAug 2025Early FundingCo-investor
OncoMyx TherapeuticsDec 2021Series B-
WugenJul 2021Series BCo-investor
Onchilles PharmaJun 2021Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014
AUM$600M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.